Ibnsina Pharma (EGX:ISPH)
Egypt
· Delayed Price · Currency is EGP 10.30
-0.52 (-4.81%)
At close: Mar 9, 2026
Ibnsina Pharma Ratios and Metrics
Market cap in millions EGP. Fiscal year is January - December.
Millions EGP. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 10,382 | 11,814 | 7,056 | 3,165 | 2,419 | 3,907 | Upgrade
|
| Market Cap Growth | 56.53% | 67.43% | 122.93% | 30.83% | -38.08% | -20.04% | Upgrade
|
| Enterprise Value | 36,079 | 35,439 | 23,168 | 15,142 | 11,020 | 10,960 | Upgrade
|
| Last Close Price | 10.30 | 11.72 | 6.90 | 3.10 | 2.13 | 3.23 | Upgrade
|
| PE Ratio | 13.46 | 15.32 | 14.17 | 18.28 | 17.84 | 13.65 | Upgrade
|
| Forward PE | 7.57 | 8.77 | 11.62 | 10.44 | 3.90 | 9.83 | Upgrade
|
| PS Ratio | 0.14 | 0.15 | 0.13 | 0.09 | 0.11 | 0.18 | Upgrade
|
| PB Ratio | 3.73 | 4.24 | 3.47 | 2.18 | 1.92 | 2.69 | Upgrade
|
| P/TBV Ratio | 4.08 | 4.64 | 3.89 | 2.57 | 1.97 | 2.72 | Upgrade
|
| P/OCF Ratio | - | - | - | 25.16 | 6.69 | - | Upgrade
|
| PEG Ratio | - | 0.26 | 0.26 | 0.35 | 0.35 | 0.41 | Upgrade
|
| EV/Sales Ratio | 0.47 | 0.46 | 0.42 | 0.45 | 0.50 | 0.50 | Upgrade
|
| EV/EBITDA Ratio | 9.34 | 9.54 | 9.69 | 11.96 | 18.48 | 13.97 | Upgrade
|
| EV/EBIT Ratio | 10.19 | 10.01 | 10.26 | 13.15 | 22.85 | 16.42 | Upgrade
|
| EV/FCF Ratio | -44.78 | - | - | - | - | - | Upgrade
|
| Debt / Equity Ratio | 9.58 | 9.58 | 9.94 | 9.06 | 7.82 | 5.49 | Upgrade
|
| Debt / EBITDA Ratio | 6.91 | 6.91 | 8.08 | 9.83 | 14.82 | 9.47 | Upgrade
|
| Net Debt / Equity Ratio | 9.23 | 9.23 | 9.53 | 8.28 | 7.39 | 5.17 | Upgrade
|
| Net Debt / EBITDA Ratio | 6.92 | 6.92 | 8.10 | 9.48 | 15.62 | 9.57 | Upgrade
|
| Net Debt / FCF Ratio | -31.90 | -31.90 | -16.31 | -52.59 | -21.33 | -15.39 | Upgrade
|
| Asset Turnover | 2.36 | 2.36 | 2.37 | 2.16 | 1.84 | 2.12 | Upgrade
|
| Inventory Turnover | 9.47 | 9.47 | 10.53 | 10.82 | 8.30 | 9.02 | Upgrade
|
| Quick Ratio | 0.71 | 0.71 | 0.67 | 0.68 | 0.60 | 0.66 | Upgrade
|
| Current Ratio | 1.02 | 1.02 | 1.00 | 1.00 | 1.00 | 1.03 | Upgrade
|
| Return on Equity (ROE) | 39.54% | 39.54% | 35.32% | 15.75% | 12.60% | 22.31% | Upgrade
|
| Return on Assets (ROA) | 6.83% | 6.83% | 5.98% | 4.58% | 2.50% | 4.06% | Upgrade
|
| Return on Invested Capital (ROIC) | 11.46% | 12.55% | 11.32% | 7.63% | 4.81% | 5.87% | Upgrade
|
| Return on Capital Employed (ROCE) | 79.00% | 79.00% | 70.20% | 43.90% | 20.10% | 35.40% | Upgrade
|
| Earnings Yield | 7.43% | 8.06% | 8.71% | 6.75% | 7.13% | 8.05% | Upgrade
|
| FCF Yield | -7.76% | -6.82% | -16.82% | -7.21% | -18.05% | -12.49% | Upgrade
|
| Dividend Yield | 1.48% | - | 2.32% | - | - | 2.66% | Upgrade
|
| Payout Ratio | 21.12% | 21.12% | 4.17% | 10.74% | 81.35% | 4.63% | Upgrade
|
| Buyback Yield / Dilution | - | - | - | - | 22.58% | -16.25% | Upgrade
|
| Total Shareholder Return | 1.48% | - | 2.32% | - | 22.58% | -13.59% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.